Medication Adherence in the Real World: Lessons from the Diuretic Comparison Project
Authors:
- Colleen A. HynesCHColleen A. Hynes
- Cynthia HauCHCynthia Hau
- Patricia WoodsPWPatricia Woods
- Sarah LeathermanSLSarah Leatherman
- Sonia T. AnandSASonia T. Anand
- Peter GlassmanPGPeter Glassman
- Addison TaylorATAddison Taylor
- William C. CushmanWCWilliam C. Cushman
- Areef IshaniAIAreef Ishani
- Ryan FergusonRFRyan Ferguson
Open Access
- 12 August 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5695
Abstract
Background/Objectives: Antihypertensive treatment is crucial for preventing major adverse cardiovascular events, but suboptimal adherence remains a challenge. Methods: This is a secondary analysis of routine care data from a large pragmatic trial comparing two thiazide diuretics: chlorthalidone (CTD) and hydrochlorothiazide (HCTZ). In the trial, 13,523 older hypertensive patients were randomized from 72 Veterans Affairs medical centers. Medication possession ratio (MPR), reflecting adherence to either study medication (CTD or HCTZ), was used and compared across all randomized patients. Results: The overall median MPR was 95% for all randomized patients and 80% for 6656 individuals who reached 2.4 years for the average follow-up. Lower MPR was observed in Black, separated, urban-living, and comorbid patients. About 30% of the participants (n = 4022) were categorized as non-adherent using a definition of MPR < 80%. Those with baseline systolic blood pressure ≥ 136, recent smoking history, and prior heart failure and Black participants had decreased odds of having an MPR ≥ 80%, while increased odds of reaching that threshold were observed in those who had an eGFR ≥ 60, received ≥3 antihypertensive medications, were married, or resided in rural areas. Conclusions: This analysis provided assessment of real-world medication adherence in a sizable older hypertensive cohort. The proportion of non-adherence found in our analysis was comparable to national trends for US older adults taking blood pressure medications. Identifying sociodemographic characteristics and health conditions associated with non-adherence can help clinicians design targeted interventions for improved adherence to clinically prescribed medications. This is important as hypertension and the older adult population are both expected to grow significantly in the future.Keywords
Funding Information
- Veterans Affairs Cooperative Studies Program (CSP) (CSP #597)
This publication has 40 references indexed in Scilit:
- Strategies for secondary use of real-world clinical and administrative data for outcome ascertainment in pragmatic clinical trialsJournal of Biomedical Informatics, 2024
- A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic TrialsJAMA Network Open, 2023
- Overcoming barriers to patient adherence: the case for developing innovative drug delivery systemsNature Reviews Drug Discovery, 2023
- Design of a pragmatic clinical trial embedded in the Electronic Health Record: The VA's Diuretic Comparison ProjectContemporary Clinical Trials, 2022
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysisThe Lancet, 2021
- Medication adherence and its determinants in patients after myocardial infarctionScientific Reports, 2020
- Interventions to Improve Medication AdherenceJAMA, 2018
- Understanding Adherence Requires Pragmatic TrialsJAMA Pediatrics, 2015
- Antihypertensive Medication Adherence, Ambulatory Visits, and Risk of Stroke and DeathJournal of General Internal Medicine, 2010
- Antihypertensive Medication Adherence in the Department of Veterans AffairsThe American Journal of Medicine, 2007